SANGAMO THERAPEUTICS, INC files current report with SEC

SANGAMO THERAPEUTICS, INC filed an 8-K covering SEC Item 1.03 and an acquisition or disposition of assets. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.